Alpha-1_antitrypsin_deficiency - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Arrowhead initiates Phase II/III trial of RNAi therapeutic ARO-AAT

Photomicrograph of a liver biopsy from a patient with alpha-1 antitrypsin deficiency. Credit: Jerad M Gardner, MD.